Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4456111000168117 | Lurasidone (Apo) (lurasidone hydrochloride 40 mg) tablet, 28 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4456121000168112 | Lurasidone (Apo) 40 mg tablet, 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lurasidone (Apo) 40 mg tablet, 28, blister pack | Is a | Lurasidone (Apo) 40 mg tablet, 28 | true | Inferred relationship | Some | ||
| Lurasidone (Apo) 40 mg tablet, 28, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Lurasidone (Apo) 40 mg tablet, 28, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Lurasidone (Apo) 40 mg tablet, 28, blister pack | has TP | Lurasidone (Apo) | true | Inferred relationship | Some | ||
| Lurasidone (Apo) 40 mg tablet, 28, blister pack | has TPUU | Lurasidone (Apo) 40 mg tablet | true | Inferred relationship | Some | 972189057 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Australian dialect reference set
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR